2023
DOI: 10.1007/s00406-023-01595-w
|View full text |Cite
|
Sign up to set email alerts
|

Treatment of negative symptoms in schizophrenia: a challenge for clinical research

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2024
2024
2024
2024

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 10 publications
0
1
0
Order By: Relevance
“…Schizophrenia is a psychiatric disorder characterized by psychotic symptoms (hallucinations, delusions and disorganized speech); negative symptoms (such as decreased motivation and diminished expressiveness) and cognitive deficits (impaired executive functions, memory and speed of mental processing) (Marder et al, 2019 ). It typically emerges in late adolescence or young adulthood, persisting throughout life (Schmitt et al, 2023 ). The global age-standardized point prevalence of schizophrenia in 2016 was estimated to be 0.28% (Charlson et al, 2018 ).…”
Section: Introductionmentioning
confidence: 99%
“…Schizophrenia is a psychiatric disorder characterized by psychotic symptoms (hallucinations, delusions and disorganized speech); negative symptoms (such as decreased motivation and diminished expressiveness) and cognitive deficits (impaired executive functions, memory and speed of mental processing) (Marder et al, 2019 ). It typically emerges in late adolescence or young adulthood, persisting throughout life (Schmitt et al, 2023 ). The global age-standardized point prevalence of schizophrenia in 2016 was estimated to be 0.28% (Charlson et al, 2018 ).…”
Section: Introductionmentioning
confidence: 99%